Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Exp Pharmacol Physiol ; 43(3): 319-26, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26707795

RESUMO

Manufactured nanomaterials have a variety of medical applications, including diagnosis and targeted treatment of cancer. A series of experiments were conducted to determine the pharmacokinetic, biodistribution and biocompatibility of two novel magnetic nanoparticles (MNPs) in the anaesthetized pig. Dimercaptosuccinic acid (DMSA) coated superparamagnetic iron oxide nanoparticles (MF66-labelled 12 nm, core nominal diameter and OD15 15 nm); at 0.5, or 2.0 mg/kg) were injected intravenously. Particles induced a dose-dependent decrease in blood pressure following administration which recovered to control levels several minutes after injection. Blood samples were collected for a 5-h period and stored for determination of particle concentration using particle electron paramagnetic resonance (pEPR). Organs were harvested post-mortem for magnetic resonance imaging (MRI at 1.5 T field strength) and histology. OD15 (2.0 mg/kg) MNP had a plasma half-life of approximately 15 min. Both doses of the MF66 (0.5 and 2.0 mg/kg) MNP were below detection limits. MNP accumulation was observed primarily in the liver and spleen with MRI scans which was confirmed by histology. MRI also showed that both MNPs were present in the lungs. The results show that further modifications may be required to improve the biocompatibility of these particles for use as diagnostic and therapeutic agents.


Assuntos
Compostos Férricos/química , Compostos Férricos/farmacocinética , Imãs , Suínos , Anestesia , Animais , Pressão Sanguínea/efeitos dos fármacos , Compostos Férricos/efeitos adversos , Compostos Férricos/sangue , Pulmão/citologia , Pulmão/efeitos dos fármacos , Imageamento por Ressonância Magnética , Tamanho da Partícula , Distribuição Tecidual
2.
Nanomedicine (Lond) ; 10(11): 1751-60, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26080697

RESUMO

AIM: Superparamagnetic iron oxide nanoparticles (SPIONs) may play an important role in nanomedicine by serving as drug carriers and imaging agents. In this study, we present the biodistribution and pharmacokinetic properties of SPIONs using a new detection method, particle electron paramagnetic resonance (pEPR). MATERIALS & METHODS: The pEPR technique is based on a low-field and low-frequency electron paramagnetic resonance. pEPR was compared with inductively coupled plasma mass spectrometry and MRI, in in vitro and in vivo. RESULTS: The pEPR, inductively coupled plasma mass spectrometry and MRI results showed a good correlation between the techniques. CONCLUSION: The results indicate that pEPR can be used to detect SPIONs in both preclinical and clinical studies.


Assuntos
Compostos Férricos/administração & dosagem , Nanomedicina , Nanopartículas/administração & dosagem , Animais , Meios de Contraste/administração & dosagem , Meios de Contraste/química , Espectroscopia de Ressonância de Spin Eletrônica , Compostos Férricos/análise , Humanos , Imageamento por Ressonância Magnética , Nanopartículas/análise , Ratos , Distribuição Tecidual
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...